The Transcription Factor Mrr1p Controls Expression of the MDR1 Efflux Pump and Mediates Multidrug Resistance in Candida albicans
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Constitutive overexpression of the MDR1 (multidrug resistance) gene, which encodes a multidrug efflux pump of the major facilitator superfamily, is a frequent cause of resistance to fluconazole and other toxic compounds in clinical Candida albicans strains, but the mechanism of MDR1 upregulation has not been resolved. By genome-wide gene expression analysis we have identified a zinc cluster transcription factor, designated as MRR1 (multidrug resistance regulator), that was coordinately upregulated with MDR1 in drug-resistant, clinical C. albicans isolates. Inactivation of MRR1 in two such drug-resistant isolates abolished both MDR1 expression and multidrug resistance. Sequence analysis of the MRR1 alleles of two matched drug-sensitive and drug-resistant C. albicans isolate pairs showed that the resistant isolates had become homozygous for MRR1 alleles that contained single nucleotide substitutions, resulting in a P683S exchange in one isolate and a G997V substitution in the other isolate. Introduction of these mutated alleles into a drug-susceptible C. albicans strain resulted in constitutive MDR1 overexpression and multidrug resistance. By comparing the transcriptional profiles of drug-resistant C. albicans isolates and mrr1Delta mutants derived from them and of C. albicans strains carrying wild-type and mutated MRR1 alleles, we defined the target genes that are controlled by Mrr1p. Many of the Mrr1p target genes encode oxidoreductases, whose upregulation in fluconazole-resistant isolates may help to prevent cell damage resulting from the generation of toxic molecules in the presence of fluconazole and thereby contribute to drug resistance. The identification of MRR1 as the central regulator of the MDR1 efflux pump and the elucidation of the mutations that have occurred in fluconazole-resistant, clinical C. albicans isolates and result in constitutive activity of this trancription factor provide detailed insights into the molecular basis of multidrug resistance in this important human fungal pathogen.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

![Figure 2 Construction of mrr1Δ Mutants and Complemented Strains (A) Structure of the deletion cassette from plasmid pZCF36M2 (top), which was used to delete the MRR1 ORF in strains SC5314, F5, G5, and CAG48B, and genomic structure of the MRR1 locus in the parental strains (bottom). The MRR1 coding region is represented by the white arrow and the upstream and downstream regions (5′MRR1 and 3′MRR1) by the solid lines. The SAT1 flipper cassette (SAT1-FLIP), in which the caFLP gene is expressed from the inducible SAP2 promoter [30], is represented by the grey rectangle bordered by FRT sites (black arrows). The 34 bp FRT sites are not drawn to scale. The probes used for Southern hybridization analysis of the mutants are indicated by the black bars. (B) Structure of the DNA fragments from plasmids pZCF36K2, pZCF36K3, pZCF36K4, and pZCF36K5 (top), which were used for integration the MRR1 F2–1, MRR1 F5, MRR1 G2–2, and MRR1 G5 alleles, respectively, into the disrupted mrr1 locus of homozygous and heterozygous mrr1Δ mutants (bottom) using the caSAT1 selection marker (grey arrow). TACT1, transcription termination sequence of the ACT1 gene. Only relevant restriction sites are given in (A) and (B): A, ApaI; B, BglII; E, EcoRI; N, NsiI; Nd, NdeI; P, PstI; S, SalI; ScI, SacI; ScII, SacII; X, XhoI. The PstI and NsiI sites shown in parenthesis were destroyed by the cloning procedure. (C) Southern hybridization of NsiI-digested genomic DNA of mrr1Δ mutants derived from strain SC5314 and of strains with reinserted MRR1 alleles with the MRR1-specific probe 1. The sizes of the hybridizing fragments (in kb) are given on the left side of the blot and their identities are indicated on the right. The genotype of the strains is given above the respective lanes. Only one of the two independently constructed series of strains is shown. Inactivation of MRR1 in the clinical isolates F5 and G5 and the reporter strain CAG48B and reinsertion of different MRR1 alleles in mrr1 mutants of the reporter strain occurred in an analogous fashion.](https://figures.cochat.ai/paper-figures/92ad36a1a1ee4d74832061200ec93001/the-transcription-factor-mrr1p-controls-expression-of-the-mdr1-efflux-pump-and-figure-2.jpg)




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The mutual dependence of Mrr1 and Snf2 occupancy at the MDR1 promoter is consistent with their requirements for MDR1 transcriptional activation (17) (Fig. 1).”
From Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Hyperactivation of Mrr1 by xenobiotics and the subsequent expression of MDR1 play a key role in detoxifying compounds such as benomyl (17, 19–21).”
From Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Interestingly, deletion of MRR1 in each MDR1-overexpressing isolate did not yield identical MICs to strains lacking MDR1 in the same background.”
From Molecular and genetic basis of azole antifungal resistance in the opportunistic pathogenic fungus Candida albicans (2020) · cites this paper as [103]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Expression of MDR1 is the major, but not the exclusive, fluconazole resistance pathway in strains with MRR1GOF mutations (17, 19).”
From Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance (2017) · cites this paper as [17]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“MRR1GOF mutations induce drug efflux gene expression and are commonly found in fluconazole-resistant C. albicans clinical isolates (1, 2, 17, 18).”
From Candida albicans Swi/Snf and Mediator Complexes Differentially Regulate Mrr1-Induced MDR1 Expression and Fluconazole Resistance (2017) · cites this paper as [17]
Experimental — accuracy not yet measured
18 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical, Cellular, and Molecular Factors That Contribute to Antifungal Drug Resistance
White, T. C., Marr, K. A., & Bowden, R. A. (1998) · Clinical Microbiology Reviews · doi:10.1128/cmr.11.2.382 · Cited by 1,353 · cited 1×
“candidiasis, which frequently affects HIV-infected persons and AIDS patients [2].”
BackgroundA rapid and simple method for preparation of RNA from Saccharomyces cerevisiae
Schmitt, M. E., Brown, T. A., & Trumpower, B. L. (1990) · Nucleic Acids Research · doi:10.1093/nar/18.10.3091 · Cited by 1,338 · cited 1×
“Total RNA was isolated using the hot SDS-phenol method [52].”
MethodSanglard, D., Kuchler, K., Ischer, F., Pagani, J. L., Monod, M., & Bille, J. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.11.2378 · Cited by 815 · cited 1×
“years ago [3], many studies have shown that the major mechanism of resistance to the widely used antifungal agent fluconazole in clinical C.”
BackgroundThe SAT1 flipper, an optimized tool for gene disruption in Candida albicans
Reuß, O., Vik, Å., Kolter, R., & Morschhäuser, J. (2004) · Gene · doi:10.1016/j.gene.2004.06.021 · Cited by 742
Self-citationWhite, T. C. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.7.1482 · Cited by 612 · cited 2×
“isolates from the same patient, so-called matched isolates, have proved an excellent tool to study the molecular basis of drug resistance [3–10].”
MethodSanglard, D., Ischer, F., Monod, M., & Bille, J. (1997) · Microbiology · doi:10.1099/00221287-143-2-405 · Cited by 587
Prasad, R., De Wergifosse, P., Goffeau, A., & Balzi, E. (1995) · Current Genetics · doi:10.1007/bf00352101 · Cited by 486
Perea, S., López-Ribot, J. L., Kirkpatrick, W. R., McAtee, R. K., Santillán, R. A., Martı́nez, M., Calabrese, D., Sanglard, D., & Patterson, T. F. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2676-2684.2001 · Cited by 470 · cited 2×
“isolates from the same patient, so-called matched isolates, have proved an excellent tool to study the molecular basis of drug resistance [3–10].”
MethodSanglard, D., Ischer, F., Koymans, L., & Bille, J. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.2.241 · Cited by 465 · cited 1×
“isolates from the same patient, so-called matched isolates, have proved an excellent tool to study the molecular basis of drug resistance [3–10].”
MethodCoste, A. T., Karababa, M., Ischer, F., Bille, J., & Sanglard, D. (2004) · Eukaryotic Cell · doi:10.1128/ec.3.6.1639-1652.2004 · Cited by 407 · cited 8×
“Two main factors, namely 1) the discovery of a cis-regulatory element in the promoters of CDR1 and CDR2 with features that are typical of binding sites of zinc cluster transcription factors, and 2) the observation that homozygosity at the mating type locus was linked with the development of azole resistance in certain…”
BackgroundInfluential
Research works printed but not linked: 1
- OddsFC 1988 Candida and candidosis: a review and bibliography London Bailliere Tindall
Cited by
Items 301–359 of 359
Morschhäuser, J. (2017) · Springer eBooks · doi:10.1007/978-3-319-50409-4_19 · Cited by 1
Self-citationTranscriptome in Human Mycoses
Peres, N. T. A., Bitencourt, T. A., Persinoti, G. F., Lang, E. A. S., Rossi, A., & Martinez-Rossi, N. M. (2022) · Springer eBooks · doi:10.1007/978-3-030-87821-4_17 · Cited by 1
Drug resistance in pathogenic species of Candida
Jaiswal, N., & Kumar, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91643-1.00014-4 · Cited by 3
Functional Genomic and Chemical Biology Analysis of Echinocandin Resistance in Candida albicans
Caplan, T. (2018) · TSpace (University of Toronto) · Cited by 1
Doorley, L. A. (2023) · doi:10.21007/etd.cghs.2023.0620 · Cited by 1
Alex, D. (2011) · DigitalGeorgetown (Georgetown University Library)
Role of the Yap Family in the Transcriptional Response to Oxidative Stress in Yeasts
Goudot, C., Devaux, F., & Lelandais, G. (2012) · InTech eBooks · doi:10.5772/33234
“…mutations were observed as being related to clinical azole resistance and (ii) genome-wide studies identified several of their target genes as being involved in the general response to oxidative stress (Liu et al., 2007; Morschhauser et al., 2007; Znaidi et al., 2009; Znaidi et al., 2008).”
Miguel, C. M. (2012) · InTech eBooks · doi:10.5772/32603
“Another Pdr1/Pdr3 homologous transcription factor, Mrr1, was found to control the expression of MDR1, in both fluconazole-resistant clinical isolates and in benomyl-or hydrogen peroxidechallenged cells (Morschhauser et al. 2007).”
BackgroundKnobloch, M. (2012) · Universitätsbibliothek der FU Berlin Hochschulschriftenstelle u. Dokumentenserver · doi:10.17169/refubium-8150
Mechanisms of Multidrug Resistance in Fungal Pathogens
Ferrari, S., & Sanglard, D. (2009) · Springer eBooks · doi:10.1007/978-3-642-03150-2_15
The Fungal Pathogen Candida albicans
Fanning, S., & Mitchell, A. P. (2014) · ASM Press eBooks · doi:10.1128/9781555816636.ch46
Global transcriptional responses of Candida albicans to histone acetyltranferases deletion
Ghalehnoo, Z. R. (2009) · Gredos (University of Salamanca) · doi:10.14201/gredos.76304
Vasicek, E. M. (2013) · doi:10.21007/etd.cghs.2013.0335
“Isolate G5 has a G997V amino acid substitution in Mrr1p, resulting in increased MDR1 expression and is also homozygous for an ERG11 mutation (152, 195).”
InfluentialApplication of gene chip technique in studying drug resistance genes in Candida albicans
Ma, Z. (2008) · Academic Journal of Second Military Medical University · doi:10.3724/sp.j.1008.2008.00211
Pós-Graduação, P. D., Eduardo, C., & Teixeira, C. (2014) · Cited by 1
ERG11-Mediated Azole Resistance in Candida albicans
Flowers, S. A. (2013) · doi:10.21007/etd.cghs.2013.0096
“40 constitutive activation, leading to the overexpression of Mdr1 (43, 127).”
BackgroundMethodResultInfluentialSun, N. (2013) · DigitalGeorgetown (Georgetown University Library)
Shekhar‐Guturja, T. (2016) · TSpace (University of Toronto)
The Roles of Hsp90 and Calcineurin in Antifungal Drug Resistance
Singh, S. (2012) · TSpace (University of Toronto)
Xie, J. L. (2017) · TSpace (University of Toronto) · Cited by 2
Luna, A. (2016) · doi:10.21007/etd.cghs.2016.0417
“This is often a consequence of gain of function mutations in the genes encoding the transcription factors Tac1p (131) (which regulates CDR1 and CDR2) and Mrr1p (132) (which regulates MDR1) (133), leading to hyperactivity of the transcription factor and the overexpression of the target genes.”
BackgroundAz antifungális rezisztencia és a virulencia összefüggésének vizsgálata Candida parapsilosis-ban
Papp, C. (2019) · SZTE Repository of Dissertations (University of Szeged) · doi:10.14232/phd.9943
An Investigation into Clinically Relevant Determinants of Azole Resistance in Candida albicans
Nishimoto, A. T. (2019) · doi:10.21007/etd.cghs.2019.0486
“Similar to the zinc cluster transcription factor encoding gene TAC1 in CDR1- and CDR2-overexpressing isolates, mutated MRR1 alleles were present in the MDR1overexpressing clinical isolates (104).”
BackgroundResultInfluentialEmergence of major drug resistant transport family Conserved proteins in fungi
ISMAIL, F., & YAQUB, M. S. (2020) · SINDH UNIVERSITY RESEARCH JOURNAL -SCIENCE SERIES · doi:10.26692/surj/2020.03.13
Targeting Casein Kinases in the Fungal Pathogen Candida albicans
Hyde, S. (2020) · TSpace (University of Toronto)
Multidrug Resistance Transcriptional Regulatory Networks in Candida
Rogers, P. D., & Barker, K. S. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch25 · Cited by 1
Self-citation(2008) · Yeast · doi:10.1002/yea.1563
Yibmantasiri, P. (2012) · Open Access Victoria University of Wellington | Te Herenga Waka (Figshare) · doi:10.26686/wgtn.17003284
Heitman, J., & Fu, C. (2017) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.731183815.793538397
Hube, B., & Brunke, S. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.735022480.793557943
Multidrug transporters of fungal pathogen Candida
Kumar, A., & Jha, A. (2023) · Elsevier eBooks · doi:10.1016/b978-0-443-18744-5.00005-8
Retraction: Candida auris: Virulence and antifungal drugs resistance
Al-Garawi, N. A.-H. D., Meri, M. A., & Sahib, R. A. (2023) · AIP conference proceedings · doi:10.1063/5.0181986
RetractedHafeez, A., Mushtaq, M., Hanif, M., Saadia, H., Kakar, K., Ejaz, H., Moeezullah, S., Karim, S., Pushparaj, P. N., Mustafa, M. Z., et al. (2025) · Journal of King Saud University - Science · doi:10.25259/jksus_169_2024 · Cited by 2
Draft genome sequence of Kodamaea ohmeri, an emerging human pathogen
Liu, L., Wang, Q., Wang, H., Quan, S., Wang, M., Xie, D., & Hao, Y.-E. (2025) · Genomics · doi:10.1016/j.ygeno.2025.111062
Thite, T., Jain, P., Iyer, K. A., Tenchov, R., Sasso, J. M., Balande, U., Maind, A., & Zhou, Q. A. (2025) · ChemRxiv · doi:10.26434/chemrxiv-2025-86lcw
Medicinal Plant-Derived Nanoparticles Against Pathogenic Candida species
Kadir, A. K. M. S., Zerin, F. F., Tripura, S., Dutta, T., Malek, A., Rasool, A., & Batool, S. (2025) · Springer eBooks · doi:10.1007/978-3-032-03604-9_10 · Cited by 1
Treatment strategies for controlling antifungal resistance in Candida onychomycosis
Tamimi, P., Ghaderi, A., Firooz, A., Sayyahfar, S., & Fattahi, A. (2025) · Archives of Dermatological Research · doi:10.1007/s00403-025-04371-z · Cited by 1
Functional Genomic Analysis of Protein Kinases in the Human Fungal Pathogen Candida albicans
Lee, Y. (2023) · TSpace (University of Toronto)
Cai, R., & Gu, J. (2026) · Journal of Fungi · doi:10.3390/jof12030174
Environmental adaptation of Candida albicans : the examples of persistence and chlamydosporulation
Denega, I. (2020) · theses.fr (ABES) · doi:10.70675/748584ddzf6f4z4124z9237z56d0535d3352
Invasive plants of France and Indonesia : a solution against C. albicans biofilms?
Desrini, S. (2023) · theses.fr (ABES) · doi:10.70675/c34fe8a1zd810z4358z952czadabb21dea2e
Etude des mécanismes de résistance aux azolés chez le complexe d’espèce Fusarium solani
Vermeulen, P. (2023) · theses.fr (ABES) · doi:10.70675/961a338cze3f2z4921zabf8z3c9ba37420c1
Patry-Leclaire, S. (2024) · theses.fr (ABES) · doi:10.70675/a9a9abc3zda6az43ecza9c8z841070363942
Hao, Y., Wang, R., Liao, H., Wang, M., Ye, Z., Liu, Y., Lv, Q., Zhang, D., Yan, L., & Xie, F. (2026) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2026.118991
Zhao, Z., Zhang, M., Yang, K., Liao, X., Zhang, Y., Lv, J., Chen, Y., Zhang, W., Liu, Z., Sun, P., et al. (2026) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.5c03625
Antifungal resistance: from classical mechanisms to the expanding role of acetyltransferases
Werneck, S. M. C., Gouveia‐Eufrásio, L., de Freitas, G. J. C., de Carvalho, D. S., César, I. C., Rossato, L. L., Bastos, R. W., Peres, N. T. A., & Santos, D. A. (2026) · Journal of Biomedical Science · doi:10.1186/s12929-026-01273-8
“Gene duplication events also contribute to antifungal resistance, as exemplified by amplification of MDR1 in Candida albicans and C. dubliniensi [110, 111].”
Barker, K. S., Patterson, H. P., Morschhäuser, J., Wiederhold, N. P., & Rogers, P. D. (2026) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2026.07.047
Self-citationCristy, S. A., Walker, J. N., & Lorenz, M. C. (2026) · mBio · doi:10.1128/mbio.01785-26 · Cited by 1
“This transcriptional response is similar to what is expected in response to drug treatment (44, 60, 61), despite no drug being present.”
Ortiz‐Prado, E., Vásconez-González, J., Cuenca, K. A., Núñez-Loor, F., Acosta-Muñoz, M. C., Mesias, D. A., Villarreal-Burbano, K. B., Arias-Intriago, M., & Izquierdo‐Condoy, J. S. (2026) · Tropical Medicine and Infectious Disease · doi:10.3390/tropicalmed11100279
“In C. albicans , mutations in the transcription factor gene MRR1 can increase MDR1 expression, contributing to the resistant phenotype observed in azole-resistant isolates [111,115].”
Wang, Q., Wang, H., Pan, H., Xu, Z., Cui, Q., 赵汇海, Jia, K., & 王缚鲲 (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1951876
“Tac1-and Mrr1-mediated upregulation of the efflux pump genes CDR1, CDR2 , and MDR1 increases drug efflux and lowers the intracellular concentration of azole agents (Coste et al., 2006; Morschhäuser et al., 2007).”
Jay, A., Bédard, C., Pageau, A., Gagnon‐Arsenault, I., Bautista, C., Kus, J. V., McTaggart, L. R., Dingle, T. C., Shokoples, S., Luca, D. G. D., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.10.28.762049
Genome Instability and DNA Repair
Larriba, G., & Calderone, R. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch5
Metadata
- Authors
- Morschhäuser, J., Barker, K. S., Liu, T. T., Blaß-Warmuth, J., Homayouni, R., & Rogers, P. D.
- Affiliations
- University of Würzburg (DE)
- University of Tennessee Health Science Center (US)
- University of Memphis (US)
- Corresponding author
- Morschhäuser, Joachim
- Venue
- PLoS Pathogens
- Publisher
- Public Library of Science (PLoS)
- Published
- 2007-11-02
- Volume
- 3
- Issue
- 11
- Pages
- e164
- ISSN
- 1553-7366 (ISSN-L)
- 1553-7374
- PMC
- PMC2048531
- OpenAlex
- W2008837893
- Cited by
- 355
- References
- 51
- Citations by year
- 2026: 16 · 2025: 22 · 2024: 17 · 2023: 22 · 2022: 18 · 2021: 18 · 2020: 23 · 2019: 32 · 2018: 14 · 2017: 25 · 2016: 14 · 2015: 13 · 2014: 22 · 2013: 15 · 2012: 16
- FWCI
- 10.35
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Pathogens (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Funders
- Deutsche Forschungsgemeinschaft (SFB 630, MO 846/3)
- National Institutes of Health (AI058145)
- National Institute of Allergy and Infectious Diseases (R01AI058145, AI058145, R21AI058145)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fungal and yeast genetics research
- Health Sciences › Medicine › Oncology › Drug Transport and Resistance Mechanisms
- Keywords
- MRR1, MDR1, multidrug resistance, Candida albicans, fluconazole resistance, transcription factors, efflux pumps, zinc cluster transcription factors, oxidative enzymes, drug resistance mutations, gene expression regulation, antifungal resistance
- MeSH terms
- Antifungal Agents, Base Sequence, Candida albicans, Flow Cytometry, Humans, Molecular Sequence Data, Mutation, Transcription Factors, Blotting, Southern, Fluconazole, Gene Expression, Gene Expression Regulation, Fungal, In Situ Hybridization, Genes, MDR, Reverse Transcriptase Polymerase Chain Reaction, ATP Binding Cassette Transporter, Subfamily B, Member 1, Oligonucleotide Array Sequence Analysis, Gene Expression Profiling, Drug Resistance, Multiple, Fungal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.